GlassScriptPhysician profile
Michael S Turner
NPI 1225282163
$30,527.94
in general payments reported to CMS, 2019-2025
38 companies · $2,648 in 2025
The $2,648 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,381 · 2020: $6,425 · 2021: $4,975 · 2022: $6,984 · 2023: $3,417 · 2024: $1,698 · 2025: $2,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6,504 · Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,504.18 |
| Food and Beverage | $1,258.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $25,624.82 | 2019-2025 | Tilock |
| Pylant Medical | $1,200.00 | 2022 | |
| Spine Wave, INC. | $600.00 | 2019 | |
| Medtronic, INC. | $494.31 | 2021-2025 | Kyphon Express II Kyphopak Tray, T2 Stratosphere Expandable Corpectomy System |
| Providence Medical Technology, INC. | $399.85 | 2019-2025 | |
| Integra Lifesciences Corporation | $301.36 | 2019-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Penumbra, INC. | $215.05 | 2020-2023 | Artemis |
| Medtronic USA, INC. | $186.64 | 2019-2020 | |
| Abbott Laboratories | $155.00 | 2019-2025 | Proclaim, Eterna, Octrode |
| Stryker Corporation | $141.08 | 2019-2025 | Spinejack |
| Stimwave Technologies Incorporated | $115.80 | 2019 | |
| Globus Medical, INC. | $103.57 | 2024-2025 | Altera, Hedron, Creo |
| Medical Device Business Services, INC. | $84.11 | 2023 | Teligen |
| Ulrich Medical USA, INC. | $69.35 | 2019 | |
| Biocomposites INC | $65.02 | 2023 | Stimulan |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $56.44 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Biotronik Nro, INC. | $50.16 | 2023-2024 | Prospera, Biotronik |
| Arbor Pharmaceuticals, INC. | $48.72 | 2019-2021 | |
| Orthofix Medical, INC. | $48.56 | 2020 | |
| Zimmer Biomet Holdings, INC. | $45.74 | 2019 | |
| Alphatec Spine, INC | $45.50 | 2019 | |
| Heartflow, INC. | $41.95 | 2025 | |
| Intrinsic Therapeutics | $38.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $38.52 | 2025 | Exparel |
| Surgalign Spine Technologies, INC. | $38.37 | 2019-2022 | |
| Centinel Spine, LLC | $36.35 | 2023 | Prodisc C Vivo |
| Innovation Technologies INC | $35.11 | 2021-2022 | |
| Nevro Corp. | $32.95 | 2021 | |
| Spinal Elements, INC. | $29.49 | 2024 | |
| Icotec Medical INC. | $29.26 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Theragen, INC. | $28.76 | 2022-2023 | Actastim-S |
| Davol INC. | $23.22 | 2025 | Surgiphor |
| Ebi, LLC | $21.75 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Kerecis Limited | $20.74 | 2022 | |
| Irras USA, INC. | $18.71 | 2020 | |
| Depuy Synthes Sales INC. | $18.36 | 2023 | Conduit |
| Monteris Medical Corporation | $12.71 | 2023 | Neuroblate |
| Arteriocyte Medical Systems, INC. | $11.75 | 2023 | Magellan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.